secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANNKIND CORP (MNKD)
CIK:        0000899460
Form:       8-K
Filed at:   2023-07-03T23:59:59+00:00
Accession:  0000950170-23-031202
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

MannKind: fire at contract manufacturer delays MNKD-101 clinical supply by 3-6 months
--------------------------------------------------------------------------------

- Fire at contract manufacturer's German facility producing clofazimine inhalation solution (MNKD-101).
- Production of clinical supplies delayed by 3-6 months.
- Planned Phase 2/3 clinical study initiation for later 2023 may be impacted.
- Company evaluating mitigation strategies; will update timing projections later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899460/000095017023031202/0000950170-23-031202-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899460/000095017023031202/mnkd-20230626.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-031202

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer